Anesta Corp. developed and patented a method of delivering controlled therapeutic doses of potent systemic drugs via the oral mucosal tissues.

Utah Ventures was an early investor in Salt Lake-based Anesta, which went public in 1994 and later was acquired by Cephalon (NASDAQ: CEPH) in 2000.